Olivier George Selected Research

Olivier George Research Topics

Disease

13	Tobacco Use Disorder (Nicotine Dependence) 01/2022 - 07/2010
8	Alcoholism (Alcohol Abuse) 01/2022 - 10/2012
7	Substance-Related Disorders (Drug Abuse) 01/2022 - 09/2008
7	Hyperalgesia 10/2020 - 01/2015
6	Opioid-Related Disorders (Opiate Addiction) 05/2020 - 12/2013
5	Body Weight (Weight, Body) 03/2022 - 01/2017
5	Cocaine-Related Disorders (Cocaine Addiction) 01/2022 - 04/2009
4	Substance Withdrawal Syndrome (Withdrawal Symptoms) 01/2022 - 12/2013
2	Inflammation (Inflammations) 11/2020 - 01/2020
2	Pain (Aches) 05/2020 - 01/2015
2	Hypersensitivity (Allergy) 01/2018 - 01/2015
1	Drug Overdose 01/2022
1	Chronic Pain 01/2020
1	Food Addiction 01/2020
1	Disease Progression 01/2020
1	Obsessive-Compulsive Disorder (Disorder, Obsessive-Compulsive) 12/2018
1	Weight Gain 01/2018
1	Heroin Dependence (Heroin Abuse) 08/2017
1	Mental Disorders (Mental Disorder) 01/2017
1	Acute Pain 01/2017
1	Parkinson Disease (Parkinson's Disease) 07/2014
1	Neurocognitive Disorders (Clerambault Syndrome) 07/2014
1	Gliosis 07/2014
1	Huntington Disease (Huntington's Disease) 07/2014
1	Neuroinflammatory Diseases 07/2014
1	HIV Infections (HIV Infection) 07/2014

Drug/Important Bio-Agent (IBA)

18	Nicotine FDA Link 03/2022 - 07/2010
7	Opioid Analgesics (Opioids)IBA 01/2022 - 04/2009
7	Pharmaceutical PreparationsIBA 12/2018 - 09/2008
3	Ethanol (Ethyl Alcohol)IBA 01/2022 - 04/2009
3	Cocaine (Cocaine HCl)IBA 01/2022 - 01/2018
3	Oxycodone (Oxycontin)FDA LinkGeneric 05/2021 - 01/2019
2	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 01/2022 - 01/2021
2	LeptinIBA 01/2022 - 01/2020
2	Corticotropin-Releasing HormoneIBA 01/2020 - 01/2017
2	Analgesics (Analgesic Drugs)IBA 01/2019 - 01/2017
2	Naloxone (Narcan)FDA LinkGeneric 01/2018 - 01/2017
2	CannabinoidsIBA 01/2018 - 04/2009
2	Heroin (Diamorphine)IBA 08/2017 - 12/2013
2	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 04/2015 - 02/2011
2	Dynorphins (Dynorphin)IBA 01/2014 - 12/2013
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2022
1	CannabidiolIBA 08/2021
1	Biomarkers (Surrogate Marker)IBA 05/2021
1	paraform (paraformaldehyde)IBA 05/2021
1	Cannabinoid Receptor AgonistsIBA 11/2020
1	Phosphotransferases (Kinase)IBA 11/2020
1	Dopamine (Intropin)FDA LinkGeneric 11/2020
1	Glucose (Dextrose)FDA LinkGeneric 01/2020
1	Caffeine (No Doz)FDA LinkGeneric 01/2020
1	Methamphetamine (Desoxyn)FDA LinkGeneric 01/2020
1	Dopamine D3 ReceptorsIBA 01/2019
1	VK4-116IBA 01/2019
1	EnzymesIBA 10/2018
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 05/2018
1	A-factor (Streptomyces)IBA 01/2018
1	OrexinsIBA 01/2018
1	Sufentanil (Sufenta)FDA LinkGeneric 01/2018
1	Therapeutic UsesIBA 08/2017
1	Calcium Channels (Calcium Channel)IBA 01/2017
1	Messenger RNA (mRNA)IBA 01/2017
1	Peptides (Polypeptides)IBA 01/2017
1	LipopolysaccharidesIBA 01/2017
1	6'- fluoro- 4',9'- dihydro- N,N- dimethyl- 4- phenylspiro(cyclohexane- 1,1'(3'H)- pyrano(3,4- b)indol)- 4- amineIBA 01/2017
1	NociceptinIBA 01/2017
1	Opioid Receptors (Opioid Receptor)IBA 01/2017
1	Mifepristone (RU 486)FDA Link 08/2015
1	CRF receptor type 1IBA 01/2015
1	prostaglandin R2 D-isomerase (prostaglandin D2 synthase)IBA 07/2014
1	Proteins (Proteins, Gene)FDA Link 07/2014
1	NetrinsIBA 07/2014
1	Prostaglandin D2IBA 07/2014
1	InterferonsIBA 07/2014
1	Illicit Drugs (Recreational Drugs)IBA 12/2013
1	Opiate AlkaloidsIBA 12/2013
1	gamma-Aminobutyric Acid (GABA)IBA 10/2012
1	Varenicline (Chantix)FDA Link 02/2011
1	EndocannabinoidsIBA 04/2009

Therapy/Procedure

14	Self Administration (Administration, Self) 10/2020 - 02/2011
3	Therapeutics 01/2019 - 08/2017
1	Pain Management 01/2019
1	Biological Therapy 10/2018
1	Deep Brain Stimulation 08/2017